You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(600196.SH):參股投資企業普靈生物擬進行A-2輪融資

格隆匯5月31日丨復星醫藥(600196.SH)公佈,本集團參股投資企業普靈生物擬進行A-2輪融資,於本次增資中,本公司控股企業蘇州星未來基金、第三方紅樹林投資擬現金出資共計人民幣1,683.3333萬元認繳標的公司新增註冊資本合計人民幣1,230,506.79元,其中:蘇州星未來基金擬現金出資人民幣750萬元認繳標的公司新增註冊資本人民幣548,245.61元(即本次投資)。與此同時,鑑於投資策略等方面因素的綜合考慮,作為標的公司本輪融資前的存續投資人股東之一,本公司控股子公司上海復拓於2024年5月31日出具《放棄優先認購權確認函》,將放棄行使依據《A1輪股東協議》就標的公司本次增資項下新增註冊資本(其中包括前述蘇州星未來基金擬認繳部分)所享有的優先認購權。本次增資(其中包括本次投資及本次放棄優先認購權)完成後,本集團(通過上海復拓和蘇州星未來基金)對普靈生物的持股比例將增至12.60%(本次增資前為10.65%);本集團對普靈生物仍將按金融資產進行財務核算。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account